• If you are wondering whether Ensign Group's current share price lines up with its underlying worth, you are not alone in asking if the stock still offers value after its recent run.
• The stock closed at US$175.93, with returns of 28.7% over 1 year and 117.5% over 5 years, although the past month shows an 11.1% pullback and a 5.6% decline over 7 days, leaving year to date returns at 1.2%.
• Recent attention on Ensign Group has centered on how the market is reassessing healthcare operators and their ability to manage costs and growth. This has added extra focus on balance sheet strength, cash generation and how much investors are willing to pay for those qualities.
• Simply Wall St's valuation model currently gives Ensign Group a value score of 1 out of 6, so it is worth comparing what different valuation approaches say about the stock today and then looking at an even richer way of thinking about value at the end of this article.

Ensign Group scores just 1/6 on our valuation checks. See what other red flags we found in the full valuation breakdown.

Approach 1: Ensign Group Discounted Cash Flow (DCF) Analysis

A Discounted Cash Flow, or DCF, model looks at the cash Ensign Group is expected to generate in the future and then discounts those cash flows back to a single value today. It is essentially asking what those future dollars are worth in present terms.

For Ensign Group, the model used is a 2 Stage Free Cash Flow to Equity approach, based on cash flow projections. The latest twelve month free cash flow is about $410.5 million. Analysts have provided estimates out to 2028, with free cash flow for that year projected at $394.0 million. Beyond those analyst years, Simply Wall St extrapolates additional annual free cash flow figures out to 2035, with each future year discounted back to today.

Pulling all of those discounted cash flows together, the model estimates an intrinsic value of about $164.13 per share. Compared with the recent share price of $175.93, the DCF output suggests the stock is around 7.2% overvalued, which is a relatively small gap rather than an extreme mismatch.

Result: ABOUT RIGHT

Ensign Group is fairly valued according to our Discounted Cash Flow (DCF), but this can change at a moment's notice. Track the value in your watchlist or portfolio and be alerted on when to act.

Approach 2: Ensign Group Price vs Earnings

For profitable companies, the P/E ratio is a useful way to think about value because it ties what you pay directly to the earnings the business is already generating. The level of P/E investors are comfortable with usually reflects what they expect for future earnings growth and how much risk they see in those earnings.

Ensign Group currently trades on a P/E of about 28.1x. That sits above the Healthcare industry average P/E of 22.4x and also above the peer group average of 15.5x. On the surface, this points to investors paying a higher price for each dollar of earnings compared with many other Healthcare stocks.

Simply Wall St also provides a proprietary “Fair Ratio” that estimates what a more tailored P/E might look like, given factors such as earnings growth, profit margins, industry, market cap and specific risks. This is often more informative than a simple comparison with industry or peers because it aims to account for the company’s own profile rather than treating all Healthcare stocks as alike. For Ensign Group, the Fair Ratio is 23.8x, which is below the current 28.1x P/E. This indicates that the stock is trading above that fair value range.

Result: OVERVALUED

P/E ratios tell one story, but what if the real opportunity lies elsewhere? Start investing in legacies, not executives. Discover our 19 top founder-led companies.

Upgrade Your Decision Making: Choose your Ensign Group Narrative

Earlier it was mentioned that there is an even better way to understand valuation. Narratives are worth a look because they let you connect your view of Ensign Group’s story with your own assumptions for future revenue, earnings and margins. They link those assumptions to a clear financial forecast, and then arrive at a Fair Value that can be compared with the current share price on Simply Wall St’s Community page. Narratives are easy to use, update automatically when new news or earnings are released, and can differ widely. For example, one Ensign Group Narrative might assume strong revenue growth and higher margins that support a higher Fair Value, while another might assume slower growth, more modest margins and a lower Fair Value. This can lead each investor to a different conclusion about whether the stock appears attractive or stretched at today’s price.

Do you think there's more to the story for Ensign Group? Head over to our Community to see what others are saying!

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.